A recent study published in the Journal of Affective Disorders suggests that a single dose of psilocybin may offer hope for U ...

The app, called Rejoyn, is cleared as a supplement to currently approved therapies and works by using specifically designed ...

Addition of the antipsychotic lumateperone (Caplyta) to an existing antidepressant improved symptoms of depression in a ...

Patients with non-seasonal depression who were treated with bright light therapy reported a 40% remission rate, according to a recent study.

especially treatment-resistant depression. Of the nearly 9 million people with major depression in the United States who have ...

David Walt, the Hansjörg Wyss Professor of Bioinspired Engineering at HMS and professor of pathology at Brigham and Women’s Hospital, is operating at a microscopic level, observing cell abnormalities ...

Researchers found that a 10-week course of home-based transcranial direct current stimulation (tDCS) significantly improved ...

If you’re feeling depressed and looking for a solution, there are many options: medications, CBT, DBT, somatic therapy and so ...

Bipolar disorder is a long-term mood disorder characterized by major fluctuations in mood — both high and low — that can ...

Alto Neuroscience’s depression treatment failed to beat placebo just nine months after the biotech went public. The stunning ...